Next Article in Journal
Implication of Ceramide Kinase/C1P in Cancer Development and Progression
Next Article in Special Issue
Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers
Previous Article in Journal
Post-Irradiation Sinus Mucosa Disease in Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Proton Therapy
Previous Article in Special Issue
Is There Still a Place for Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma at the Time of Immunotherapies? A Focus on Lenvatinib
 
 
Review

Article Versions Notes

Cancers 2022, 14(1), 226; https://doi.org/10.3390/cancers14010226
Action Date Notes Link
article xml file uploaded 4 January 2022 05:59 CET Original file -
article xml uploaded. 4 January 2022 05:59 CET Update https://www.mdpi.com/2072-6694/14/1/226/xml
article pdf uploaded. 4 January 2022 05:59 CET Version of Record https://www.mdpi.com/2072-6694/14/1/226/pdf
article html file updated 4 January 2022 06:00 CET Original file -
article html file updated 4 January 2022 06:00 CET Update -
article html file updated 31 July 2022 01:53 CEST Update https://www.mdpi.com/2072-6694/14/1/226/html
Back to TopTop